This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lewicki, H.
Right arrow Articles by Oldstone, M. B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewicki, H.
Right arrow Articles by Oldstone, M. B. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Creutzfeldt-Jakob Disease

 Previous Article  |  Next Article 

Journal of Virology, March 2003, p. 3799-3808, Vol. 77, No. 6
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.6.3799-3808.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

T Cells Infiltrate the Brain in Murine and Human Transmissible Spongiform Encephalopathies{dagger}

Hanna Lewicki,1 Antoinette Tishon,1 Dirk Homann,1 Honoré Mazarguil,2 Françoise Laval,2 Valerie C. Asensio,3 Iain L. Campbell,3 Stephen DeArmond,4 Bryan Coon,1 Chao Teng,1 Jean Edouard Gairin,2 and Michael B. A. Oldstone1*

Division of Virology, Department of Neuropharmacology (IMM-6), The Scripps Research Institute, La Jolla, California 92037,1 Institut de Pharmacologie et de Biologie Structurale-UMR 5089, CNRS, 31077 Toulouse, Cedex 4, France,2 Department of Neuropharmacology (CVN-9),3 Department of Pathology, University of California—San Francisco, San Francisco, California 941434

Received 12 August 2002/ Accepted 26 November 2002

CD4 and CD8 T lymphocytes infiltrate the parenchyma of mouse brains several weeks after intracerebral, intraperitoneal, or oral inoculation with the Chandler strain of mouse scrapie, a pattern not seen with inoculation of prion protein knockout (PrP-/-) mice. Associated with this cellular infiltration are expression of MHC class I and II molecules and elevation in levels of the T-cell chemokines, especially macrophage inflammatory protein 1ß, IFN-{gamma}-inducible protein 10, and RANTES. T cells were also found in the central nervous system (CNS) in five of six patients with Creutzfeldt-Jakob disease. T cells harvested from brains and spleens of scrapie-infected mice were analyzed using a newly identified mouse PrP (mPrP) peptide bearing the canonical binding motifs to major histocompatibility complex (MHC) class I H-2b or H-2d molecules, appropriate MHC class I tetramers made to include these peptides, and CD4 and CD8 T cells stimulated with 15-mer overlapping peptides covering the whole mPrP. Minimal to modest Kb tetramer binding of mPrP amino acids (aa) 2 to 9, aa 152 to 160, and aa 232 to 241 was observed, but such tetramer-binding lymphocytes as well as CD4 and CD8 lymphocytes incubated with the full repertoire of mPrP peptides failed to synthesize intracellular gamma interferon (IFN-{gamma}) or tumor necrosis factor alpha (TNF-{alpha}) cytokines and were unable to lyse PrP-/- embryo fibroblasts or macrophages coated with 51Cr-labeled mPrP peptide. These results suggest that the expression of PrPsc in the CNS is associated with release of chemokines and, as shown previously, cytokines that attract and retain PrP-activated T cells and, quite likely, bystander activated T cells that have migrated from the periphery into the CNS. However, these CD4 and CD8 T cells are defective in such an effector function(s) as IFN-{gamma} and TNF-{alpha} expression or release or lytic activity.


* Corresponding author. Mailing address: Division of Virology, Department of Neuropharmacology, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858) 784-8054. Fax: (858) 784-9981. E-mail: mbaobo{at}scripps.edu.

{dagger} This is publication number 13546-NP from the Department of Neuropharmacology, The Scripps Research Institute, La Jolla, Calif.


Journal of Virology, March 2003, p. 3799-3808, Vol. 77, No. 6
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.6.3799-3808.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Gourdain, P., Gregoire, S., Iken, S., Bachy, V., Dorban, G., Chaigneau, T., Debiec, H., Bergot, A.-S., Renault, I., Aucouturier, P., Carnaud, C. (2009). Adoptive Transfer of T Lymphocytes Sensitized against the Prion Protein Attenuates Prion Invasion in Scrapie-Infected Mice. J. Immunol. 183: 6619-6628 [Abstract] [Full Text]  
  • Tang, Y., Xiang, W., Hawkins, S. A. C., Kretzschmar, H. A., Windl, O. (2009). Transcriptional Changes in the Brains of Cattle Orally Infected with the Bovine Spongiform Encephalopathy Agent Precede Detection of Infectivity. J. Virol. 83: 9464-9473 [Abstract] [Full Text]  
  • Riemer, C., Schultz, J., Burwinkel, M., Schwarz, A., Mok, S. W. F., Gultner, S., Bamme, T., Norley, S., van Landeghem, F., Lu, B., Gerard, C., Baier, M. (2008). Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3-/- Mice. J. Virol. 82: 12464-12471 [Abstract] [Full Text]  
  • Sacquin, A., Bergot, A. S., Aucouturier, P., Bruley-Rosset, M. (2008). Contribution of Antibody and T Cell-Specific Responses to the Progression of 139A-Scrapie in C57BL/6 Mice Immunized with Prion Protein Peptides. J. Immunol. 181: 768-775 [Abstract] [Full Text]  
  • Haviv, Y., Avrahami, D., Ovadia, H., Ben-Hur, T., Gabizon, R., Sharon, R. (2008). Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin. Arch Neurol 65: 762-775 [Abstract] [Full Text]  
  • Kercher, L., Favara, C., Striebel, J. F., LaCasse, R., Chesebro, B. (2007). Prion Protein Expression Differences in Microglia and Astroglia Influence Scrapie-Induced Neurodegeneration in the Retina and Brain of Transgenic Mice. J. Virol. 81: 10340-10351 [Abstract] [Full Text]  
  • Spinner, D. S., Kascsak, R. B., LaFauci, G., Meeker, H. C., Ye, X., Flory, M. J., Kim, J. I., Schuller-Levis, G. B., Levis, W. R., Wisniewski, T., Carp, R. I., Kascsak, R. J. (2007). CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils. J. Leukoc. Biol. 81: 1374-1385 [Abstract] [Full Text]  
  • Eaton, S. L., Rocchi, M., Gonzalez, L., Hamilton, S., Finlayson, J., Sales, J., Jeffrey, M., Steele, P. J., Dagleish, M. P., Rodger, S. M., Reid, H. W., Chianini, F. (2007). Immunological differences between susceptible and resistant sheep during the preclinical phase of scrapie infection. J. Gen. Virol. 88: 1384-1391 [Abstract] [Full Text]  
  • Khalili-Shirazi, A., Quaratino, S., Londei, M., Summers, L., Tayebi, M., Clarke, A. R., Hawke, S. H., Jackson, G. S., Collinge, J. (2005). Protein Conformation Significantly Influences Immune Responses to Prion Protein. J. Immunol. 174: 3256-3263 [Abstract] [Full Text]  
  • Schultz, J., Schwarz, A., Neidhold, S., Burwinkel, M., Riemer, C., Simon, D., Kopf, M., Otto, M., Baier, M. (2004). Role of Interleukin-1 in Prion Disease-Associated Astrocyte Activation. Am. J. Pathol. 165: 671-678 [Abstract] [Full Text]  
  • Gregoire, S., Logre, C., Metharom, P., Loing, E., Chomilier, J., Rosset, M. B., Aucouturier, P., Carnaud, C. (2004). Identification of two immunogenic domains of the prion protein--PrP--which activate class II-restricted T cells and elicit antibody responses against the native molecule. J. Leukoc. Biol. 76: 125-134 [Abstract] [Full Text]  
  • Tenzer, S., Stoltze, L., Schonfisch, B., Dengjel, J., Muller, M., Stevanovic, S., Rammensee, H.-G., Schild, H. (2004). Quantitative Analysis of Prion-Protein Degradation by Constitutive and Immuno-20S Proteasomes Indicates Differences Correlated with Disease Susceptibility. J. Immunol. 172: 1083-1091 [Abstract] [Full Text]